Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.04
+0.06 (0.55%)
At close: Dec 5, 2025, 4:00 PM EST
11.32
+0.28 (2.54%)
After-hours: Dec 5, 2025, 5:11 PM EST
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $322.17 million as of December 5, 2025. Its market cap has decreased by -6.03% in one year.
Market Cap
322.17M
Enterprise Value
145.26M
1-Year Change
-6.03%
Ranking
Category
Stock Price
$11.04
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $322.17M, a decrease of -19.88%. That is a compound annual growth rate of -12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 322.17M | -14.69% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 926.87B |
| Johnson & Johnson | 495.47B |
| AbbVie | 405.35B |
| UnitedHealth Group | 305.59B |
| AstraZeneca | 282.37B |
| Merck & Co. | 254.53B |
| Novartis AG | 253.36B |
| Thermo Fisher Scientific | 220.07B |